| Targeting the EGFR signaling pathway in cancer therapy P Seshacharyulu, MP Ponnusamy, D Haridas, M Jain, AK Ganti, SK Batra Expert opinion on therapeutic targets 16 (1), 15-31, 2012 | 979 | 2012 |
| Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy P Mukhopadhyay, S Chakraborty, MP Ponnusamy, I Lakshmanan, M Jain, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1815 (2), 224-240, 2011 | 237 | 2011 |
| Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies MP Torres, MP Ponnusamy, S Chakraborty, LM Smith, S Das, HA Arafat, ... Molecular cancer therapeutics 9 (5), 1419-1431, 2010 | 192 | 2010 |
| MUC16 as a novel target for cancer therapy A Aithal, S Rauth, P Kshirsagar, A Shah, I Lakshmanan, WM Junker, ... Expert opinion on therapeutic targets 22 (8), 675-686, 2018 | 191 | 2018 |
| MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells MP Ponnusamy, I Lakshmanan, M Jain, S Das, S Chakraborty, P Dey, ... Oncogene 29 (42), 5741-5754, 2010 | 160 | 2010 |
| MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells I Lakshmanan, MP Ponnusamy, S Das, S Chakraborty, D Haridas, ... Oncogene 31 (7), 805-817, 2012 | 156 | 2012 |
| Pathobiological implications of MUC16 expression in pancreatic cancer D Haridas, S Chakraborty, MP Ponnusamy, I Lakshmanan, S Rachagani, ... PloS one 6 (10), e26839, 2011 | 154 | 2011 |
| Concise review: current status of three-dimensional organoids as preclinical models G Kaushik, MP Ponnusamy, SK Batra Stem Cells 36 (9), 1329-1340, 2018 | 153 | 2018 |
| MUC16: molecular analysis and its functional implications in benign and malignant conditions D Haridas, MP Ponnusamy, S Chugh, I Lakshmanan, P Seshacharyulu, ... The FASEB Journal 28 (10), 4183-4199, 2014 | 153 | 2014 |
| Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation N Momi, MP Ponnusamy, S Kaur, S Rachagani, SS Kunigal, ... Oncogene 32 (11), 1384-1395, 2013 | 140 | 2013 |
| Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications I Lakshmanan, MP Ponnusamy, MA Macha, D Haridas, PD Majhi, S Kaur, ... Journal of Thoracic Oncology 10 (1), 19-27, 2015 | 136 | 2015 |
| Human RNA polymerase II-associated factor complex: dysregulation in cancer K Chaudhary, S Deb, N Moniaux, MP Ponnusamy, SK Batra Oncogene 26 (54), 7499-7507, 2007 | 127 | 2007 |
| Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer AP Singh, S Senapati, MP Ponnusamy, M Jain, SM Lele, JS Davis, ... The lancet oncology 9 (11), 1076-1085, 2008 | 124 | 2008 |
| Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1–CD44 Axis P Nallasamy, RK Nimmakayala, S Karmakar, F Leon, P Seshacharyulu, ... Gastroenterology 161 (6), 1998-2013. e7, 2021 | 110 | 2021 |
| Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets S Chugh, VS Gnanapragassam, M Jain, S Rachagani, MP Ponnusamy, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1856 (2), 211-225, 2015 | 101 | 2015 |
| MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells MP Ponnusamy, AP Singh, M Jain, S Chakraborty, N Moniaux, SK Batra British journal of cancer 99 (3), 520-526, 2008 | 101 | 2008 |
| Ovarian cancer: emerging concept on cancer stem cells MP Ponnusamy, SK Batra Journal of ovarian research 1, 1-9, 2008 | 100 | 2008 |
| Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling MA Macha, S Rachagani, S Gupta, P Pai, MP Ponnusamy, SK Batra, ... Cancer letters 341 (2), 166-177, 2013 | 96 | 2013 |
| Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin S Rachagani, S Senapati, S Chakraborty, MP Ponnusamy, S Kumar, ... British journal of cancer 104 (6), 1038-1048, 2011 | 95 | 2011 |
| Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells R Vengoji, MA Macha, RK Nimmakayala, S Rachagani, JA Siddiqui, ... Journal of Experimental & Clinical Cancer Research 38, 1-13, 2019 | 94 | 2019 |
